Speaker: Dimitrios P. Kontoyiannis, MD, ScD, Professor, Section of Infectious Diseases, Department of Internal Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas
Posaconazole (Noxafil, Schering-Plough), a novel, extended-spectrum triazole antifungal agent, may offer an attractive oral treatment alternative for patients with zygomycosis who cannot tolerate or do not respond to IV amphotericin B formulations [...]

Speaker: Henry S. Sacks, MD, PhD, Professor of Community Medicine, Medicine, and Biomathematics, Mount Sinai School of Medicine, New York, New York
In hospitalized patients who are starting antibiotic therapy, the simultaneous administration of probiotics such as live, nonpathogenic microorganisms (e.g., Lactobacillus or Sac-charomyces) may prevent antibiotic-associated diarrhea (AAD) and reduce costs, and it probably saves [...]

Speaker: Michael Corrado, MD, Physician of Infectious Diseases and President and Chief Executive Officer, Advanced Biologics, New Hope, Pennsylvania
Faropenem medoxomil (Orapem, Replidyne, Inc.), an investigative oral penem antibiotic with potent activity against Staphylococcus aureus and Streptococcus pyogenes, proved to be at least as effective as generic amoxicillin/clavulanate (Augmentin canadian, GlaxoSmithKline) in the treatment of uncomplicated [...]

Telithromycin Preferred for Acute Maxillary Sinusitis
Speaker: Itzhak Brook, MD, MSc, Professor, Department of Pediatrics, Georgetown University School of Medicine, Washington, DC
The ketolide telithromycin (Ketek, Sanofi Aventis) has been found to be more effective than the macrolide azithromycin (Zithromax generic, Pfizer) in eradicating Streptococcus pneumoniae from the nasopharynges of patients with acute maxillary sinusitis. Furthermore, the [...]